| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $-1.32 (Miss by $-0.39) |
| EPS GAAP Actual | $-1.32 (Miss by $-0.39) |
| Revenue Actual | $0.053869B |
| Revenue Surprise | Beat by $53.869M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.42894 |
| EPS GAAP Estimate | $-0.42894 |
| Revenue Estimate | $0.071209437B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.98404 | 1.12 | 1.9253 | 2.04379 | 1 |
| Dec 2028 | 2.03822 | 1.09 | 1.97788 | 2.0996 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.46 | -0.39785 | 0.053869B | -8.43% | -5.55M |
| FQ2 2025 (Jun 2025) | 0.33 | 0.33 | 0.060782B | -8.35% | 60.78M |
| FQ1 2025 (Mar 2025) | -0.33 | -0.33 | 0.113119B | 17.82% | 113.12M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.315181B | 21.42% | 315.18M |
| FQ3 2024 (Sep 2024) | -2.57 | -2.57 | 0.058409B | -10.8% | 58.41M |
| FQ2 2024 (Jun 2024) | -0.96 | -0.96 | 0.065856B | -1.38% | 65.86M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 0.092964B | 20.7% | 92.96M |
| FQ4 2023 (Dec 2023) | 1.78 | 1.78 | 0.247662B | 20.73% | 247.66M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.42894
Consensus Revenue Estimates
0.071209437B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.04828 | -- | 2.94596 | 3.1778 | 1 |
| FQ3 2027 (Sep 2027) | -1.12885 | -- | -1.19344 | -1.04081 | 1 |
| FQ2 2027 (Jun 2027) | -0.88272 | -- | -0.93322 | -0.81387 | 1 |
| FQ1 2027 (Mar 2027) | -0.42268 | -- | -0.44686 | -0.38971 | 1 |
| FQ4 2026 (Oct 2026) | -1.22105 | -- | -1.30144 | -1.14503 | 0 |
| FQ3 2026 (Jul 2026) | -0.75277 | -93.95 | -0.80233 | -0.7059 | 0 |
| FQ2 2026 (Jun 2026) | -0.84356 | 139.12 | -0.91873 | -0.74653 | 0 |
| FQ1 2026 (Mar 2026) | -0.42894 | 23.07 | -0.46716 | -0.3796 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.41B | -- | 0.39B | 0.42B | 2 |
| FQ3 2027 (Sep 2027) | 0.05B | -- | 0.05B | 0.05B | 1 |
| FQ2 2027 (Jun 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
| FQ1 2027 (Mar 2027) | 0.12B | -- | 0.11B | 0.12B | 1 |
| FQ4 2026 (Oct 2026) | 0.07B | -- | 0.06B | 0.07B | 1 |
| FQ3 2026 (Jul 2026) | 0.06B | 15.03 | 0.06B | 0.07B | 1 |
| FQ2 2026 (Jun 2026) | 0.08B | 21.89 | 0.07B | 0.08B | 1 |
| FQ1 2026 (Mar 2026) | 0.07B | -58.85 | 0.06B | 0.08B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -1.06215 | -1.46 | -0.39785 | 27.25% |
| FQ2 2025 (Jun 2025) | 0.33 | 0.33 | 100% | |
| FQ1 2025 (Mar 2025) | -0.33 | -0.33 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | -2.57 | -2.57 | 100% | |
| FQ2 2024 (Jun 2024) | -0.96 | -0.96 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 1.78 | 1.78 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.06B | $0.05B | $-5.55M | -10.31% |
| FQ2 2025 (Jun 2025) | $0B | $0.06B | $60.78M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.11B | $113.12M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.32B | $315.18M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.06B | $58.41M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.07B | $65.86M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.09B | $92.96M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.25B | $247.66M | 100% |